Michael Basin
@michaelbasinmd
Urology resident @UrologyUpstate, @KECKSchool_USC '20, @UCLA '15.
Cali native. Giants, Niners, Warriors, Liverpool.
Views are my own, RTs ≠ endorsement
ID: 1199933205299642369
28-11-2019 06:09:16
54 Tweet
176 Takipçi
250 Takip Edilen
Congratulations to our boss Dr Gennady Bratslavsky MD for his Distinguished Service to society of Urologic Oncology Society of Urologic Oncology #aua23 Upstate Urology
#AUA23 Amer. Urol. Assn. 👉comparing the complete response (CR) rates of TAR-200 with reported CR rates of Pembrolizumab vs Nadofaregene F👉TAR-200 may become new SOC in near future. Great AE profile. OncoAlert UroToday.com Bladder Cancer Advocacy Network
JUST IN (and finally...): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!! The time has finally come... via Business Wire Dana-Farber Lank Center for Genitourinary Oncology Tom Powles OncoAlert Oncology Brothers OncLive.com Targeted Oncology UroToday.com Uromigos Alliance for Clinical Trials in Oncology ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network
Thankful to be one of the recipients of the ASCO Merit Award! Couldn’t have done it without the support of my amazing mentors Joe Jacob MD, MCR, Dr. Ross, and Dr. Bratslavsky, as well as all of Upstate Urology.
Unlocking the genetic code! Michael Basin delves into FGFR3 mutations in #UrothelialCarcinoma at ##GU24, this study reveals intriguing distinctions in bladder vs. upper tract cases. Written coverage by Zach Klaassen on UroToday > bit.ly/3ubtvXM ASCO
Impressive results presented by Joe Jacob MD, MCR at #AUA2024 from SunRISE-1 trial showing 82.8% CR rate at anytime and 12mo DOR 74.6%. Well tolerated. Andrea Necchi Hussein Sweiti, MD IBCG Bladder Cancer Advocacy Network
Congratulations to our rockstar chief class for matching to their top fellowship programs! Michael Basin ➡️ Uro Onc USC Urology Carla Miguel ➡️ Endo/MIS UMN Urology Rebecca Sager ➡️ Uro Onc UrologyMSK SUNY Upstate Urology Residency Upstate Cancer Center Upstate Medical University YUO Endourological Society
You don’t want to miss it! Everything I was looking for in a program, all at one place! - Fantastic faculty, co-residents, and nurses - Surgical autonomy - Basic science and clinical research opportunities (conferences paid for) - Low cost of living #UroSoMe The Urology Applicant ⚕
Listen to our very own Joe Jacob MD, MCR discuss findings from a new study using Jelmyto (UGN-101) on ureteral tumors! 🚨50% complete response rate, 26% partial response rate‼️ 🚑 Only 5% ureteral stricture rate #UroSoMe UroToday.com urotoday.com/video-lectures…
Tremendous effort by splernerMD & colleagues on this SWOG Cancer Research Network S1011 trial. Practice changing trial. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer nejm.org/doi/full/10.10… Rob Svatek Kamal Pohar Anne Schuckman Ashish M. Kamat, MD, MBBS Sumanta K. Pal, MD, FASCO Gary Steinberg
Fresh off the press! Joe Jacob MD, MCR and I discuss new and up-and-coming treatments in BCG-unresponsive NMIBC
Congrats to our newest residents! #MatchDay #UrologyMatch #UroMatch25 The Urology Applicant ⚕ #StreamTeam Inside The Match
Chief residents Dr. Basin and Dr. Sager presenting at the annual GU ASCO meeting in San Francisco! Upstate Urology Foundation Medicine ASCO #GU25 #urology #urores
Joe Jacob presenting highly anticipated 1 yr durability study from SunRISe-1 study showing the excellent results. More options soon to be available for our #NMIBC Stephanie Chisolm, PhD Bladder Cancer Advocacy Network IBCG Bladder Cancer Advocacy Network Félix Guerrero-Ramos Andrea Necchi Evanguelos Xylinas
Upstate Urology representing at AUA! Congrats to chief resident Dr. Basin and his mentors Dr. Mollapour Mehdi Mollapour PhD and Dr. Bratslavsky for winning best poster!!! Amer. Urol. Assn. #AUA25 #Urology #Urosome
